VAIM Opens Global Training Center at Seoul Office

VAIM Opens Global Training Center at Seoul Office

VAIM announced the completion and official launch of its Global Training Center at the Seoul office, located on the fifth floor and completed in late November.

The newly established Global Training Center is dedicated to delivering specialized educational programs for international medical professionals. It is designed to serve as a global academic hub, enabling in-depth sharing of the clinical value of Juvelook, while disseminating the latest injection techniques and promoting international academic exchange.

Shortly after its completion, on December 3, the Global Training Center successfully hosted the December 2025 Monthly Meeting of the BoFilTh Clinical Research Society. The event demonstrated the center’s advanced educational environment and provided a meaningful platform for active knowledge exchange among domestic and international medical professionals.

A VAIM representative stated, “With the completion of the Global Training Center, we have established a strong foundation to systematically deliver Juvelook’s scientific evidence and proper injection techniques to medical professionals worldwide. We will continue to enhance Juvelook’s brand credibility through differentiated educational content.”

Introduction of VAIM
Founded in 2014, VAIM is a global medical aesthetics company that develops human tissue regeneration products and improved pharmaceuticals by utilizing its accumulated technology and know-how in biocompatible and biodegradable polymers. It has developed and patented a PDLLA-based manufacturing technology that reduces the risk of nodule formation compared to other ingredient structures, and in 2019, its subsidiary, VAIM, entered the skin booster market with JUVELOOK, which utilizes this technology. JUVELOOK is a collagen booster that induces the production of ECM (collagen, elastin) to provide direct remodeling effects on the skin such as elasticity and wrinkle improvement, and is divided into JUVELOOK and LENISNA depending on the purpose. After quickly proving its safety and effectiveness since its launch, VAIM currently has product export contracts with 72 countries.